â– LECTURE OVERVIEW: Preeclampsia is a multi-system, pregnancy-specific vasospastic disorder characterized by abnormal placental vascular remodeling.
â– BIOCHEMICAL PATHWAYS:
1. Spiral Artery Maladaptation: The primary defect is the failure of cytotrophoblasts to invade and remodel maternal spiral arteries. The arteries remain narrow, high-resistance vessels, leading to chronic placental ischemia.
2. Endothelial Injury: The ischemic placenta secretes anti-angiogenic factors (e.g., sFlt-1) that cause widespread maternal endothelial damage.
3. Systemic Vasospasm: Endothelial damage disrupts nitric oxide pathways, causing systemic vasospasm.
4. Glomerular Endotheliosis: Glomerular capillary endothelial swelling restricts filtration, presenting as proteinuria and elevated serum creatinine.
5. End-organ Vasoconstriction: Leads to cerebral edema (seizure risk), hepatic necrosis, and pulmonary edema.
â– CLINICAL DIAGNOSTIC METRICS:
Establishing a definitive diagnosis requires combining serum biomarkers with gold-standard diagnostic modalities. High-sensitivity ELISAs are used initially to minimize false negatives, followed by highly specific confirmatory testing.
â– EVIDENCE-BASED GUIDELINE SYNOPSIS:
Recent international multi-center guidelines emphasize starting therapeutic interventions immediately upon diagnosis to minimize long-term target organ strain.
[HY-BOARD-1042]
🌟 Dynamic Clinical Key:
Preeclampsia is diagnosed by new-onset hypertension (BP >140/90 mmHg) presenting after 20 weeks gestation, accompanied by proteinuria (>300 mg/24h) or end-organ dysfunction. Severe cases can progress to HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelets). Treat with IV Magnesium Sulfate for seizure prophylaxis. Always correlate elevated serum spikes with continuous vital readings to rule out false laboratory spikes. Consult updated medical consensus reports to align treatment protocols with modern precision standards.